Markus Axelsson

机构：Sahlgrenska University Hospital, Region Västra Götaland, University of Gothenburg · ORCID：0000-0003-2036-4007

发表论文 116 篇 · 总被引 5426 次 · h-index 32

代表论文

• Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial (2022 · The Lancet Neurology · 被引 140)
• Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing–remitting multiple sclerosis (2023 · Journal of Neurology · 被引 47)
• Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures (2023 · Epilepsia · 被引 34)
• Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis (2024 · Journal of Neurology · 被引 27)
• Decreased Incidence of Guillain-Barré Syndrome during the COVID-19 Pandemic: A Retrospective Population-Based Study (2022 · Neuroepidemiology · 被引 23)
• High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis (2023 · Frontiers in Immunology · 被引 21)